Review of primary and salvage cryoablation for prostate cancer

Cancer Control

Volumn 14, Issue 3, 2007, Pages 231-237

  Chin, Joseph L ^a   Lim, Darwin ^a   Abdelhady, Mazen ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BIOLOGY; CANCER CONTROL; CANCER PATIENT; CLINICAL ASSESSMENT; CRYOABLATION; CRYOSURGERY; EXPERIENCE; HISTORY; HUMAN; LANGUAGE; LITERATURE; OUTCOME ASSESSMENT; PATIENT SELECTION; PENIS ERECTION; PREDICTOR VARIABLE; PRIMARY CRYOABLATION; PROSTATE CANCER; QUALITY OF LIFE; RADIATION; REVIEW; RISK; SAFETY; SALVAGE CRYOABLATION; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34447344251     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480701400305     Document Type: Review

References (54)

1. Gonder MJ, Soanes WA, Smith V. Experimental prostate cryosurgery. Invest Urol. 1964;1:610-619.
2. Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Invest Urol. 1966;3:372-378.
3. Flocks RH, Nelson CM, Boatman DL. Perineal cryosurgery for prostatic carcinoma. J Urol. 1972;108:933-935.
4. Megalli MR, Gursel EO, Veenema RJ. Closed perineal cryosurgery in prostate cancer. New probe and technique. Urology. 1974;4:220-222.
5. Onik GM, Cohen JK, Reyes GD, et al. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993;72:1291-1299.
6. Lee F, Bahn DK, McHugh TA, et al. US-guided percutaneous cryoablation of prostate cancer. Radiology. 1994;192:769-776.
7. Cohen JK, Miller RJ. Thermal protection of urethra during cryosurgery of prostate. Cryobiology. 1994;31:313-316.
8. Wong WS, Chinn DO, Chinn M, et al. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer. 1997;79:963-974.
9. Cohen JK, Miller RJ, Shuman BA, et al. Urethral warming catheter for use during cryoablation of the prostate. Urology. 1995;45:861-864.
10. Zisman A, Pantuck AJ, Cohen JK, et al. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template: technique and preliminary results. Urology. 2001; 58:988-993.
11. Rewcastle JC, Sandison GA, Saliken JC, et al. Consideration during clinical operation of two commercially available cryomachines. J Surg Oncol. 1999;71:106-111.
12. Chin JL, Downey DB, Mulligan M, et al. Three-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in nonsurgical candidates: a feasibility study and report of early results. J Urol. 1998;159:910-914.
13. Zisman A, Leibovici D, Siegel YI, et al. Prostate cryoablation without an insertion kit using direct transperineal placement of ultrathin freezing probes. Tech Urol. 2000;6:34-36.
14. Chin JL, Downey DB, Onik G, et al. Three-dimensional prostatic ultrasound and its application to cryosurgery. Tech Urol. 1996;2:187-193.
15. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology. 1998;37:171-186.
16. Borkowski P, Robinson MJ, Poppiti RJ Jr, et al. Histologic findings in postcryosurgical prostatic biopsies. Mod Pathol. 1996;9:807-811.
17. Grampsas SA, Miller GJ, Crawford ED. Salvage radical prostatectomy after failed transperineal cryotherapy: histologic findings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images. Urology. 1995;45:936-941.
18. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int. 2005;95:1187-1191.
19. Patel BG, Parsons CL, Bidair M, et al. Cryoablation for carcinoma of the prostate. J Surg Oncol. 1996;63:256-264.
20. Lee F, Bahn DK, Badalament RA, et al. Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes. Urology. 1999;54:135-140.
21. Chin JL, Ng CK, Abdelhady M, et al. Results of a controlled, randomized trial of primary cryoablation versus external beam radiotherapy for locally advanced prostate cancer. J Urol. 2006;175(suppl):363. Abstract 1130.
22. Porter MP, Ahaghotu CA, Loening SA, et al. Disease-free and overall survival after cryosurgical monotherapy for clinical stages B and C carcinoma of the prostate: a 20-year followup. J Urol. 1997;158:1466-1469.
23. Long JP, Bahn D, Lee F, et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. 2001;57:518-523.
24. Ellis DS. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology. 2002;60:34-39.
25. Shinohara K, Connolly JA, Presti JC Jr, et al. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996;156:115-121.
26. Koppie TM, Shinohara K, Grossfeld GD, et al. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience. J Urol. 1999;162:427-432.
27. Prepelica KL, Okeke Z, Murphy A, et al. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer. 2005;103:1625-1630.
28. Bahn DK, Lee F, Badalament R, et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60(2 suppl 1):3-11.
29. Donnelly BJ, Saliken JC, Ernst DS, et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002;60:645-649.
30. Han KR, Cohen JK, Miller RJ, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003(4 pt 1);170:1126-1130.
31. Anastasiadis AG, Sachdev R, Salomon L, et al. Comparison of health-related quality of life and prostate-associated symptoms after primary and salvage cryotherapy for prostate cancer. J Cancer Res Clin Oncol. 2003;129:676-682. Epub 2003 Oct 21.
32. Donnelly BJ, Saliken JC, Ali-Ridha N, et al. Histological findings in the prostate two years following cryosurgical ablation. Can J Urol. 2001;8:1237-1239.
33. Robinson JW, Moritz S, Fung T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys. 2002;54:1063-1068.
34. Robinson JW, Donnelly BJ, Saliken JC, et al. Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology. 2002;60:12-18.
35. Robinson JW, Donnelly BJ, Coupland K, et al. Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy. Urol Oncol. 2006;24:472-486.
36. Kang SH, Kim JW, Bae JH, et al. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients. Asian J Androl. 2006;8:629-636.
37. Chin JL, Pautler SE, Mouraviev V, et al. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol. 2001;165(6 pt 1):1937-1942.
38. Pisters LL, Perrotte P, Scott SM, et al. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol. 1999;17:2514-2520.
39. Greene GF, Pisters LL, Scott SM, et al. Predictive value of prostate specific antigen nadir after salvage cryotherapy. J Urol. 1998;160:86-90.
40. Izawa JI, Madsen LT, Scott SM, et al. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol. 2002;20:2664-2671.
41. Ng CK, Abdelhady M, Touma N, et al. Salvage cryoablation outcomes: analysis of predictive factors in a large cohort of patients. J Urol. 2006;175(suppl):363. Abstract 1128.
42. Ghafar MA, Johnson CW, de La Taille A, et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol. 2001;166:1333-1338.
43. Chin JL, Touma N, Pautler SE, et al. Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol. 2003;170(4 pt 1):1199-1202.
44. Izawa JI, Morganstern N, Chan DM, et al. Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:468-472.
45. Miller RJ Jr, Cohen JK, Shuman B, et al. Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma. Cancer. 1996;77:1510-1514.
46. de la Tallie A, Hayek O, Benson MC, et al. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience. Urology. 2000;55:79-84.
47. Bales GT, Williams MJ, Sinner M, et al. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology. 1995;46:676-680.
48. Coogan CL, McKiel CF. Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. J Urol. 1995;154:1813-1817.
49. Spiess PE, Lee AK, Leibovici D, et al. Pre-salvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer. 2006;107:275-280.
50. Touma NJ, Izawa JI, Chin JL. Current status of local salvage therapies following radiation failure for prostate cancer. J Urol. 2005;173:373-379.
51. Perrotte P, Litwin MS, McGuire EJ, et al. Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol. 1999;162:398-402.
52. Janzen NK, Han KR, Perry KT, et al. Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model. J Endourol. 2005;19:520-525.
53. Jia Z, Davies PL. Antifreeze proteins: an unusual receptor-ligand interaction. Trends Biochem Sci. 2002;27:101-106.
54. Onik G, Narayan P, Vaughan D, et al. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology. 2002;60:109-114.